ZA738214B - Substituted 9,10-dihydroanthracenes - Google Patents

Substituted 9,10-dihydroanthracenes

Info

Publication number
ZA738214B
ZA738214B ZA738214*A ZA738214A ZA738214B ZA 738214 B ZA738214 B ZA 738214B ZA 738214 A ZA738214 A ZA 738214A ZA 738214 B ZA738214 B ZA 738214B
Authority
ZA
South Africa
Prior art keywords
dihydroanthracenes
substituted
Prior art date
Application number
ZA738214*A
Other languages
English (en)
Inventor
A Sill
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ZA738214B publication Critical patent/ZA738214B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA738214*A 1972-12-21 1973-10-23 Substituted 9,10-dihydroanthracenes ZA738214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00317129A US3838177A (en) 1972-12-21 1972-12-21 Substituted 9,10-dihydroanthracenes

Publications (1)

Publication Number Publication Date
ZA738214B true ZA738214B (en) 1974-08-28

Family

ID=23232241

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA738214*A ZA738214B (en) 1972-12-21 1973-10-23 Substituted 9,10-dihydroanthracenes

Country Status (9)

Country Link
US (1) US3838177A (hu)
JP (1) JPS4988853A (hu)
AU (1) AU474523B2 (hu)
CA (1) CA1042018A (hu)
DE (1) DE2362684A1 (hu)
FR (1) FR2211234B1 (hu)
GB (1) GB1420376A (hu)
IL (1) IL43666A (hu)
ZA (1) ZA738214B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen
AUPR393701A0 (en) * 2001-03-23 2001-04-26 Commonwealth Scientific And Industrial Research Organisation Self-reducing anthraquinone compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA956940A (en) * 1970-05-14 1974-10-29 Arthur D. Sill Bis-basic ethers of 2,6-and 2,7-dihydroxyanthraquinones

Also Published As

Publication number Publication date
JPS4988853A (hu) 1974-08-24
FR2211234B1 (hu) 1976-12-03
AU474523B2 (en) 1976-07-22
DE2362684A1 (de) 1974-06-27
AU6188173A (en) 1975-05-01
US3838177A (en) 1974-09-24
GB1420376A (en) 1976-01-07
FR2211234A1 (hu) 1974-07-19
CA1042018A (en) 1978-11-07
IL43666A (en) 1977-01-31
IL43666A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
KE2930A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
KE2670A (en) 1,2,3,-thiadiazole derivatives
GB1406961A (en) 2,4,7-trioxopteridine derivatives
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
GB1402046A (en) 11,12-epoxyerythromycins
HK15179A (en) 2,6-diaminoneburlarine derivatives
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1020953A (en) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
IL43236A0 (en) 15alpha,16alpha-methylene-delta4-pregnenes
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
GB1404278A (en) 15,17a-unsubstituted-d-homosteroids
AU472337B2 (en) 11, 12-secoprostaglandins
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
ZA733182B (en) 10,11-anhydroerythromycins
ZA731789B (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
GB1400789A (en) 1,1-azobis-benzimidazolium salts
IL43673A (en) 3,9-bis-aminoalkyl fluoranthene
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA898805A (en) Substituted 4,1-oxazepines
IL39236A0 (en) 8-aza-(3,2,1)-bicyclooctan-3-ol derivatives
ZA735169B (en) 1,4-ethano-2,3-dihydroquinoline derivatives
CA905931A (en) 3,4-diazapregnanes
CA900975A (en) 8,5 - amino - substituted-tetrahydrohalo-sulfamyl-quinazolinones
CA895310A (en) 1,2,4-triazine-5-ones
CA897172A (en) 3,4-dihydronaphthalenoneoxy-2-hydroxypropylamines